AUScelerate BioGateway China
Description
China Life Sciences Ecosystem Immersion
Shanghai & Suzhou | 23-27 November 2026
AUScelerate's BioGateway China: Ecosystem Immersion has been designed for Australian life sciences organisations seeking to better understand, engage with and build relationships within China's rapidly evolving healthcare and innovation landscape.
Over five days, delegates will gain access to leading hospitals, innovation districts, biotech clusters, funders, government and industry leaders across Shanghai and Suzhou. Participants will meet the organisations shaping China's future in clinical research, drug development, medical technology and healthcare innovation while exploring new opportunities for collaboration and growth.
This is a curated executive immersion designed to help participants understand how China's innovation ecosystem works, how partnerships are formed, and where future opportunities may emerge for Australian organisations.
Why China?
China is no longer simply a manufacturing hub or an emerging healthcare market. It's now one of the world's most dynamic life sciences ecosystems, driving innovation in clinical research, biotechnology, medical technology and translational science at unprecedented speed.
This is a market with globally competitive capabilities in:
Clinical research and trial delivery
Biotechnology and drug development
Medical technology innovation
Digital health and AI-enabled healthcare
Research translation and commercialisation
Manufacturing and supply chain excellence
For Australian organisations, understanding China's innovation ecosystem is increasingly important for identifying collaboration opportunities, supporting global growth strategies and building long-term relationships with partners across Asia.
Choose your Track
Track A: Ecosystem Immersion Designed for organisations seeking to understand China's life sciences ecosystem, clinical research landscape and innovation environment. | Track B: Executive Partnering Designed for clinical trial associated organisations actively seeking partnerships, clients and commercial opportunities. |
|---|---|
Ideal for:
| Ideal for:
|
What you get:
| What you get:
|
Who Should Attend?
This executive mission is designed for organisations operating across the life sciences sector, including:
Contract Research Organisations (CROs)
Contract Development and Manufacturing Organisations (CDMOs)
Biotech and medtech companies
Clinical trial and regulatory specialists
Commercialisation and market access advisors
Research institutes and innovation organisations
Business development and strategy leaders
Executives responsible for partnerships, growth and international expansion
Whether you're exploring China for the first time or looking to deepen existing relationships, this mission offers a structured pathway to understand the market, build connections and uncover new opportunities.
Costs
Participation in AUScelerate’s BioGateway China: Immersion Mission is:
Track A: Ecosystem Immersion $2,500 (ex. GST)*
Track B: Executive Partnering $5,000 (ex. GST)*
This fee covers the first individual from your company; for every subsequent individual from the same company, please add $1000 (ex. GST).
*NB this fee includes all catering, ground transfer between venues and fare from Shanghai to Suzhou, but does not include international travel costs and travel to/from airports.
Important dates
Delegates should plan to arrive in Shanghai by Monday 23 November 2026 noon local time for the program to commence. The program will conclude after lunch on Friday 27 November 2026.
Registration closes Friday 16 October 2026 with places limited, so we encourage you to register soon.
For any queries, please contact Dr Michelle Lam (mission coordinator, michelle.lam@auscelerate.org) or Jarrod Belcher (Director of Partnerships, jarrod.belcher@auscelerate.org).
Tickets for good, not greed Humanitix dedicates 100% of profits from booking fees to charity



